Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.
复制标题
DOI:
10.1371/journal.pone.0029257
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Mucke L
中科院分区:
文献类型:
--
作者:
Morris M;Koyama A;Masliah E;Mucke L
Many neurodegenerative diseases are increasing in prevalence and cannot be prevented or cured. If they shared common pathogenic mechanisms, treatments targeting such mechanisms might be of benefit in multiple conditions. The tau protein has been implicated in the pathogenesis of diverse neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD). Tau reduction prevents cognitive deficits, behavioral abnormalities and other pathological changes in multiple AD mouse models. Here we examined whether tau reduction also prevents motor deficits and pathological alterations in two mouse models of PD, generated by unilateral striatal injection of 6-hydroxydopamine (6-OHDA) or transgene-mediated neuronal expression of human wildtype α-synuclein. Both models were evaluated on Tau +/+, Tau +/– and Tau –/– backgrounds in a variety of motor tests. Tau reduction did not prevent motor deficits caused by 6-OHDA and slightly worsened one of them. Tau reduction also did not prevent 6-OHDA-induced loss of dopaminergic terminals in the striatum. Similarly, tau reduction did not prevent motor deficits in α-synuclein transgenic mice. Our results suggest that tau has distinct roles in the pathogeneses of AD and PD and that tau reduction may not be of benefit in the latter condition.
登录
查看更多内容
DOI:
10.1083/jcb.200605187
发表时间:
2006-11-20
期刊:
The Journal of cell biology
影响因子:
--
作者:
King ME;Kan HM;Baas PW;Erisir A;Glabe CG;Bloom GS
通讯作者:
Bloom GS
影响因子:
5.3
作者:
Frasier, M;Walzer, M;Wolozin, B
通讯作者:
Wolozin, B
影响因子:
9.9
作者:
DITTER, SM;MIRRA, SS
通讯作者:
MIRRA, SS
影响因子:
16.2
作者:
KONDO, J;HONDA, T;IHARA, Y
通讯作者:
IHARA, Y
影响因子:
168.9
作者:
Ferri, CP;Prince, M;Scazufca, M
通讯作者:
Scazufca, M